CN Patent

CN112010862B — 一种主动靶向叶酸受体近红外荧光分子及其制备方法

Assigned to Nanjing Nuoyuan Medical Devices Co Ltd · Expires 2021-03-30 · 5y expired

What this patent protects

本发明涉及近红外手术导航荧光分子及细胞标记成像等领域，具体公开了一种主动靶向近红外荧光小分子的结构及其制备方法。本发明通过利用有机全合成的方法制备了培美曲塞二钠及其衍生物为主动靶向基团的主动靶向近红外荧光小分子。这种主动靶向近红外荧光分子具有主动靶向性高、特异性强，水溶性好和荧光量子产率高等优点。

USPTO Abstract

本发明涉及近红外手术导航荧光分子及细胞标记成像等领域，具体公开了一种主动靶向近红外荧光小分子的结构及其制备方法。本发明通过利用有机全合成的方法制备了培美曲塞二钠及其衍生物为主动靶向基团的主动靶向近红外荧光小分子。这种主动靶向近红外荧光分子具有主动靶向性高、特异性强，水溶性好和荧光量子产率高等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN112010862B
Jurisdiction
CN
Classification
—
Expires
2021-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Nuoyuan Medical Devices Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.